Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 10
Submit an article Journal homepage
692
Views
9
CrossRef citations to date
0
Altmetric
Psychiatry

Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia

Phillip PierceJanssen Pharmaceutical Research and Development, USA; Correspondence[email protected]
,
Srihari GopalJanssen Pharmaceutical Research and Development, USA;
,
Adam SavitzJanssen Pharmaceutical Research and Development, USA;
,
Hong QiuJanssen Pharmaceutical Research and Development, USA;
,
Takahito HinoJanssen Pharmaceutical Research and Development, Japan;
,
Michelle BuschJanssen Pharmaceutical Research and Development, USA;
,
Akiko FujinoJanssen Pharmaceutical Research and Development, Japan;
,
Maju MathewsJanssen Global Medical Affairs, USA;
,
Takeshi KatsuJanssen Pharmaceutical Medical Affairs, Japan
,
Yoshikazu MaedaJanssen Pharmaceutical Research and Development, Japan;
,
Masayoshi TakahashiJanssen Pharmaceutical Research and Development, Japan;
&
David HoughJanssen Pharmaceutical Research and Development, USA;
show all
Pages 1671-1679 | Received 23 Feb 2016, Accepted 03 Jun 2016, Published online: 28 Jun 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

D. Boels, J. Mahé, A. Olry, A. Citterio-Quentin, J. Moragny & P. Jolliet. (2021) Fatal and life-threatening ADRs associated with paliperidone palmitate: an observational study in the French pharmacovigilance database. Clinical Toxicology 59:9, pages 786-793.
Read now

Articles from other publishers (8)

Daniel Fife, Stephen Fortin, Hong Qiu, Michiyo Yamazaki, Dean Najarian & Erica A Voss. (2022) Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations. Neuropsychopharmacology Reports 42:3, pages 347-351.
Crossref
Chao-Hsiun Tang, Darmendra Ramcharran, Ching-Wen Wendy Yang, Chi-Chun Chang, Po-Ya Chuang, Hong Qiu & Kuo-Hsuan Chung. (2021) A nationwide study of the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia in Taiwan. Schizophrenia Research 237, pages 9-19.
Crossref
Amber N. Edinoff, Prithvi K. Doppalapudi, Claudia Orellana, Caroline Ochoa, Shelby Patti, Yahya Ghaffar, Elyse M. Cornett, Aaron J. Kaye, Omar Viswanath, Ivan Urits, Adam M. Kaye & Alan D. Kaye. (2021) Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review. Frontiers in Psychiatry 12.
Crossref
D. Boels, J. Mahé, A. Olry, J. Moragny & P. Jolliet. (2021) Palmitate de palipéridone par voie intramusculaire : une iatrogénie d’origine toxique ?. Toxicologie Analytique et Clinique 33:1, pages 33.
Crossref
Dong-Eun Seo, Seonji Kim & Byung-Joo Park. (2020) Signals of Adverse Drug Reactions of Paliperidone Compared to Other Atypical Antipsychotics Using the Korean Adverse Event Reporting System Database. Clinical Drug Investigation 40:9, pages 873-881.
Crossref
Guillaume Drevin, Bruno Ripault, Jean-Baptiste Ballot-Ragaru, Estelle Bonnot, Maeva Palayer, Alexia Gaconnet, Marie Deguigne, Olivier Dubourg, Stéphane Malbranque, Nathalie Jousset & Benedicte Lelievre. (2020) Death following an intramuscular injection of paliperidone: A case report. Toxicologie Analytique et Clinique 32:2, pages 132-136.
Crossref
Koki Chiba, Takeshi Wada, Yuji Nakamura, Xin Cao, Mihoko Hagiwara-Nagasawa, Hiroko Izumi-Nakaseko, Kentaro Ando, Koichiro Tanaka, Atsuhiko T. Naito & Atsushi Sugiyama. (2017) Analysis of proarrhythmic potential of an atypical antipsychotic drug paliperidone in the halothane-anesthetized dogs. Journal of Pharmacological Sciences 134:4, pages 239-246.
Crossref
Pierre S. Chue & Arno G. Siraki. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 65 90 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.